A novel lipid compound, epolactaene, induces apoptosis: its action is modulated by its side chain structure

This publication has 17 references indexed in Scilit:

• Inhibition of p38 MAP Kinase Activity Up-Regulates Multiple MAP Kinase Pathways and Potentiates 1,25-Dihydroxyvitamin D3-Induced Differentiation of Human Leukemia HL60 Cells
  Experimental Cell Research, 2000
• Induction of apoptosis by vitamin D₃ analogue EB1089 in NCI‐H929 myeloma cells via activation of caspase 3 and p38 MAP kinase
  British Journal of Haematology, 2000
• Palmitate-induced apoptosis in cardiomyocytes is mediated through alterations in mitochondria: prevention by cyclosporin A
  Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2000
• Induction of apoptosis by novel synthesized acylamides of human lymphocytes
  Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1999
• Neuritogenic Effect of Epolactaene Derivatives on Human Neuroblastoma Cells Which Lack High-Affinity Nerve Growth Factor Receptors
  Journal of Medicinal Chemistry, 1997
• Cell-cycle arrest, micronucleus formation, and cell death in growth inhibition of MCF-7 breast cancer cells by tamoxifen and cisplatin
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1996
• Apoptosis during HL‐60 cell differentiation is closely related to a G0/G1 cell cycle arrest
  Journal of Cellular Physiology, 1995
• Epolactaene, a Novel Neuritogenic Compound in Human Neuroblastoma Cells, Produced by a Marine Fungus.
  The Journal of Antibiotics, 1995
• Retrodifferentiation and Cell Death
  Critical Reviews™ in Oncogenesis, 1994
• Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3.
  Proceedings of the National Academy of Sciences, 1981